Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study

被引:1
|
作者
Nalwanga, Damalie [1 ,2 ]
Musiime, Victor [1 ,3 ]
Bangirana, Paul [4 ]
Nishiguchi, Erika Phelps [5 ]
Kiggwe, Andrew [2 ]
Ssesanga, Titus [3 ]
Ssenkusu, John M. [6 ]
Musoke, Philippa [1 ]
Cusick, Sarah E. [7 ]
机构
[1] Makerere Univ, Sch Med, Dept Paediat & Child Hlth, Coll Hlth Sci, POB 7072, Kampala, Uganda
[2] Makerere Univ Lung Inst, POB 7749, Kampala, Uganda
[3] Joint Clin Res Ctr, Res Dept, POB 10005, Kampala, Uganda
[4] Makerere Univ, Sch Med, Dept Psychiat, Coll Hlth Sci, POB 7072, Kampala, Uganda
[5] Univ Washington, Dept Paediat, Div Dev Behav Paediat, Seattle, WA 98195 USA
[6] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Hlth Sci, POB 7072, Kampala, Uganda
[7] Univ Minnesota, Dept Paediat, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
Neurocognitive function; Children; HIV; ART; NEUROPSYCHOLOGICAL PERFORMANCE; COGNITIVE IMPAIRMENT; NAIVE; DEFICITS; OUTCOMES; CARE; ART;
D O I
10.1186/s12887-021-02676-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background HIV infection is associated with significant neurocognitive deficits making maximization of cognitive function among children receiving antiretroviral therapy (ART) a public health imperative. Non-protease inhibitors (non-PIs) achieve higher drug levels in the cerebral spinal fluid (CSF) compared to PIs, potentially leading to better neurocognitive function by reducing CSF viral load and inflammation. ART that maximises children's neurodevelopment and school achievement could result in improved quality of life and productivity as adults, but little research to date has examined whether non-PI ART is associated with better neurocognitive outcomes. We compared the neurocognitive function between children living with HIV receiving PI-based and non PI-based ART. Methods We recruited a consecutive sample of clinically stable Ugandan children living with HIV aged 5-12 years who received PI-based or non PI-based ART for >= 1 year (viral load < 1000 copies). Neurocognitive function was assessed using the Kaufman Assessment Battery for Children, the Test of Variables of Attention, and Bruininks-Oseretsky Test of Motor Proficiency. Age-adjusted neurocognitive z-scores for the two groups were compared using linear regression models in STATA version 13. The Hommel's method was used to adjust for multiple testing. Results We enrolled 76 children living with HIV; 34 on PI ART and 42 on non-PI ART. Mean (+/- SD) age was greater in the non-PI vs. PI group (9.5 +/- 1.9 vs. 8.5 +/- 2.0) years (p = 0.03). Children in the non-PI group had lower socioeconomic scores (5.7 +/- 3.3 vs. 7.4 +/- 2.8, p = 0.02). There was no difference in neurocognitive function between the groups (adjusted p > 0.05) for KABC and TOVA. Children in the PI group had better total BOT scores than their counterparts (46.07 +/- 1.40) vs. 40.51 (1.24), p = 0.03). Conclusions We detected no difference in neurocognitive function among children on PI and non PI-based ART therapy based on KABC and TOVA tests. Children on PI based ART had better motor function than their counterparts. We recommend a prospective study with a larger sample size.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study
    Gray, D. M.
    Workman, L. J.
    Lombard, C. J.
    Jennings, T.
    Innes, S.
    Grobbelaar, C. J.
    Cotton, M. F.
    Zar, H. J.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (03) : 322 - 327
  • [22] Explaining Antiretroviral Therapy Adherence Success Among HIV-Infected Children in Rural Uganda: A Qualitative Study
    Peter K. Olds
    Julius P. Kiwanuka
    Norma C. Ware
    Alexander C. Tsai
    Jessica E. Haberer
    AIDS and Behavior, 2015, 19 : 584 - 593
  • [23] Protease Genotypes in Patients Failing Protease Inhibitor-based Antiretroviral Therapy at a Pediatric Center in Botswana
    Gomila, Andres
    Kirk, Brianna
    Marape, Marape
    Anabwani, Gabriel
    Tolle, Michael
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (10) : 1086 - 1088
  • [24] Prenatal Protease Inhibitor Use and Risk of Preterm Birth among HIV-Infected Women Initiating Antiretroviral Drugs during Pregnancy
    Patel, Kunjal
    Shapiro, David E.
    Brogly, Susan B.
    Livingston, Elizabeth G.
    Stek, Alice M.
    Bardeguez, Arlene D.
    Tuomala, Ruth E.
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (07) : 1035 - 1044
  • [25] Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients
    Casado, JL
    Perez-Elías, MJ
    Antela, A
    Sabido, R
    Martí-Belda, P
    Dronda, F
    Blazquez, J
    Quereda, C
    AIDS, 1998, 12 (11) : F131 - F135
  • [26] Explaining Antiretroviral Therapy Adherence Success Among HIV-Infected Children in Rural Uganda: A Qualitative Study
    Olds, Peter K.
    Kiwanuka, Julius P.
    Ware, Norma C.
    Tsai, Alexander C.
    Haberer, Jessica E.
    AIDS AND BEHAVIOR, 2015, 19 (04) : 584 - 593
  • [27] Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment
    Wattanutchariya, N.
    Sirisanthana, V.
    Oberdorfer, P.
    HIV MEDICINE, 2013, 14 (04) : 226 - 232
  • [28] Effect of the duration of protease inhibitor therapy in HIV-infected individuals on the severity of obstructive sleep apnea
    Abdeen, Yazan
    Al-Halawani, Moh'd
    Kaako, Ahmad
    Hao, Ingrid Fang Ying
    Dazley, Jason
    Katpally, Ram
    Klukowicz, Alan
    Miller, Richard
    Slim, Jihad
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2019, 24
  • [29] Lipid Profile Changes after Switch to Atazanavir from other Protease Inhibitor-based Combined Antiretroviral Treatment in HIV-infected Korean
    Baek, Ji Hyeon
    Song, Young Goo
    Kim, Chang Oh
    Jeong, Su Jin
    Koo, Nam Soo
    Kim, Hye Won
    Han, Sang Hoon
    Choi, Jun Yong
    Kim, June Myung
    INFECTION AND CHEMOTHERAPY, 2012, 44 (05) : 377 - 381